JPMorgan Retracts Previous Optimism for US Stocks in Wake of Changing Coronavirus Reality

Despite JPMorgan issuing a relatively optimistic outlook earlier regarding the current and near future state of the US economy, much of that positive sentiment has since been reduced. According to the bank’s chief equity strategist Mislav Matejka, the second half of 2020 will now come affixed with a profoundly unattractive risk-reward, with stocks stocks continuing to suffer from diminishing cash and bonds, much like what was witnessed in the first half of the year.

The sudden bearish outlook for US stocks can be attributed to several very evident reasons. Given the current soaring pace of coronavirus infection rates across the US, it is very unlikely that a 2003 template of the SARS virus can be replicated. Although various economic projections are based on the virus tapering off following the first wave of infections, which in turn would cause consumer behaviour to resume in mirror of a V-shaped economic recovery, the reality of the situation is taking a much different pace. The US has now entered a significantly larger second wave of the deadly virus – or depending on how one looks at it, the US hasn’t even overcome the first wave.

The second reasoning behind the sudden downgrade in JPMorgan’s optimism can be associated with the development of the US-China relationship. Despite the Phase 1 trade deal remaining intact, there continues to be an increased risk of escalating tensions between the two countries, causing trade to relapse into uncertain territory once again. This thus puts further pressure on the international trade, and ultimately US manufacturing output during a time when US firms are attempting to resume production following the lifting of economic restrictions.

Lastly, the deflationary spiral that typically follows a recession causes a reduction in demand, a drop in wages, decreased production, and an even further decline in prices. Even after the initial economic shock subsides, the negative spiral continues to linger for some time. As hopes of a V-shaped economic recovery slowly slip away, forthcoming 2021 GDP projections are becoming more and more bleak – especially with the continued soaring unemployment rate. Nonetheless, as the window for mitigating the coronavirus pandemic in the US continues to close and slip away, there is a good chance that other economic projections will begin retracting their previous optimistic outlooks much like JPMorgan.

Information for this briefing was found via JPMorgan and Bloomberg. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver @ $36 & We’re Still 200M Oz Short | Paul Andre Huet – Americas Gold and Silver

Gold’s Wild Bull Run: Are Markets About to Break? | Mike McGlone

First Majestic Silver: The Santa Elena Mine

Recommended

Goliath Resources Closes Out Funding Round With Total Gross Proceeds Of $27.1 Million

Silver47 Kickstarts 4,000 Metre Drill Campaign At Red Mountain Project

Related News

Steven Mnuchin: Those Receiving $2 Million Or More Under PPP To Be Audited

As part of the CARES Act, the US federal government unveiled the Paycheck Protection Program...

Wednesday, April 29, 2020, 02:17:00 PM

How Long Can The Stock Market Ignore The Economy?

Naturally, as long as it wants. Despite constant assertions to the contrary, the stock market...

Monday, April 20, 2020, 08:20:16 AM

US Showdown With China Now Stands With Trump Wanting To “Go Back To Where We Were”

The White House announced a steep increase in tariffs on Chinese imports, bringing the total...

Friday, April 11, 2025, 02:58:00 PM

Weekly Number of Mortgages Entering Forbearance Program Increasing at an Alarming Rate

In March, the US government put in the place the CARES Act – a relief...

Saturday, April 25, 2020, 04:00:00 PM

Biotech Boom Playbook: Part 1: The Building Blocks Of Life (Science)

Between the Shroom Boom and COVID-19, the tables in the biotech wing of the micro-cap...

Monday, May 25, 2020, 04:00:00 PM